Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide.
Cureus
; 14(4): e24498, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35651410
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Cureus
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: